For Q3FY24, Glenmark Pharma’s revenue declined by 19.1% YoY (-21.8% QoQ) to INR 25,067 Mn (excluding Glenmark Life Sciences). For 9MFY24, revenue increased 2.0% YoY to INR 87,501 Mn.